Surgical Innovations Group plc designs, develops, manufactures, and sells devices for use in minimally invasive surgery (SI) and precision engineering markets. It operates through three segments: SI Brand, Original Equipment Manufacturer (OEM), and Distribution. The SI Brand segment researches, develops, manufactures, and distributes SI branded minimally invasive devices. This segment also offers YelloPort Elite and YelloPort +plus laparoscopic port access systems; LogiRange resposable laparoscopic instrument systems; FastClamp laparoscopic clamping systems; and QuickRange single use laparoscopic instrumentation. The OEM segment researches, develops, manufactures, and distributes minimally invasive devices for third party medical device companies through own label or co-branding. This segment also provides design and development solutions for producing a final device; and researches, develops, manufactures, and sells minimally invasive technology products for precision engineering applications. The Distribution segment distributes medical products through Elemental Healthcare Ltd. The company also designs and manufactures autologous blood products. It sells its products through independent healthcare distributors, as well as its own label products through OEM relationships. Surgical Innovations Group plc was founded in 1992 and is based in Leeds, the United Kingdom.
Industry, Sector and Symbol
Industry Medical Devices
Sub-IndustryN/A
SectorMedical
CIKN/A
Phone+44-113-2307597
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales£10.97 million
Profitability
Miscellaneous
Employees76
Next Earnings DateN/A
OptionableOptionable
Surgical Innovations Group (LON:SUN) Frequently Asked Questions
What is Surgical Innovations Group's stock symbol?
Surgical Innovations Group trades on the London Stock Exchange (LON) under the ticker symbol "SUN."
Has Surgical Innovations Group been receiving favorable news coverage?
Press coverage about SUN stock has trended somewhat positive this week, according to InfoTrie Sentiment. The research firm identifies negative and positive news coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Surgical Innovations Group earned a news sentiment score of 0.7 on InfoTrie's scale. They also gave news articles about the company a news buzz of 7.0 out of 10, meaning that recent news coverage is likely to have an effect on the stock's share price in the near term.
Who are some of Surgical Innovations Group's key competitors?
Some companies that are related to Surgical Innovations Group include Titan Medical (TMD), Advanced Oncotherapy (AVO), Cyclopharm (CYC), Helius Medical Technologies (HSM), Kromek Group (KMK), Impedimed (IPD), REVA Medical (RVA), Osprey Medical (OSP), Resonance Health (RHT), Protech Home Medical (PHM), Electromed (ELMD), Universal Biosensors (UBI), LBT Innovations (LBT), Avacta Group (AVCT) and Oventus Medical (OVN).
What other stocks do shareholders of Surgical Innovations Group own?
Who are Surgical Innovations Group's key executives?
Surgical Innovations Group's management team includes the folowing people:
- Mr. David John Marsh, CEO & Director
- Ms. Melanie Ross, CFO & Director (Age 39)
- Mr. Adam Power, Group Bus. Devel. Director & Director
- Mr. Alex Hogg, Operations Director
- Ms. Charmaine Day, Financial Controller & Company Sec. (Leave of Absence) (Age 37)
How do I buy shares of Surgical Innovations Group?
Shares of SUN and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
What is Surgical Innovations Group's stock price today?
One share of SUN stock can currently be purchased for approximately GBX 4.10.
How big of a company is Surgical Innovations Group?
Surgical Innovations Group has a market capitalization of £32.29 million and generates £10.97 million in revenue each year. Surgical Innovations Group employs 76 workers across the globe.
What is Surgical Innovations Group's official website?
How can I contact Surgical Innovations Group?
Surgical Innovations Group's mailing address is Clayton Wood House, 6 Clayton Wood Bank, LEEDS, LS16 6QZ, United Kingdom. The company can be reached via phone at +44-113-2307597.
MarketBeat Community Rating for Surgical Innovations Group (LON SUN)
MarketBeat's community ratings are surveys of what our community members think about Surgical Innovations Group and other stocks. Vote "Outperform" if you believe SUN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SUN will underperform the S&P 500 over the long term. You may vote once every thirty days.
